Literature DB >> 11316198

Treatment of severe esophageal Crohn's disease with thalidomide.

P M Ginsburg, I Hanan, E D Ehrenpreis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11316198     DOI： 10.1111/j.1572-0241.2001.03729.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

Review 1.  Thalidomide in cancer treatment: a potential role in the elderly?

Authors:  Shufeng Zhou; Philip Kestell; Malcolm D Tingle; James W Paxton
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

2.  Tumor necrosis factor alpha and macrophages in the brain of herpes simplex virus type 1-infected BALB/c mice.

Authors:  Mark Fields; Mei Zheng; Ming Zhang; Sally S Atherton
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

3.  Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn.

Authors:  Hao Xu; Sha-Jie Dang; Yuan-Yuan Cui; Zhen-Yu Wu; Jun-Feng Zhang; Xiao-Peng Mei; Yu-Peng Feng; Yun-Qing Li
Journal:  J Pain Res       Date:  2019-11-29       Impact factor: 3.133

4.  Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review.

Authors:  Huiqin Hu; Xinying Wang; Side Liu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.